James Blair

Verified profile

Venture Capital, Investor · United States

James Blair is a venture capital investor and investor based in the United States. They invest in Biotechnology and Pharmaceuticals, typically at the Seed stage. Their portfolio includes Zogenix, Gene Sciences, Inc., Astute Medical and Ocunexus Therapeutics and 8 other companies.

Investment stages

Industries

Portfolio companies (12)

Similar investors in Biotechnology

  • Stacey Olson

    Venture Capital · United States

    Health CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly

    Contact details available

  • Nicholas Bashour

    Private Equity Firm · United States

    AdvertisingHealth CareCommercialHospitals

    Portfolio: Linius Technologies, LDI

    Contact details available

  • Thomas Parkinson

    Venture Capital, Government Office, Private Equity Firm · United States

    Health CareTelecommunicationsAutonomous VehiclesCybersecurity

    Portfolio: Adrenaline Mobility, EarthSense, Inc.

    Contact details available

  • Meg EvansVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    SeedE-commerceEnterprise SoftwareCryptocurrencyLife Science

    Contact details available

  • Gary BenittVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    SeedEnterprise SoftwareInformation Technology (IT)MobileArchitecture

    Portfolio: Reaction, LiveStories

    Contact details available

  • Sharon KnightVerified

    Angel/Individual · United States

    SeedHealth CareHospitalsBiotechnologyMedical

    Portfolio: Knack.it, FitStar (acq. by Fitbit)

    Contact details available

  • Travis WoodVerified

    Venture Capital, Private Equity Firm, Venture Debt · United States

    AdvertisingHealth CarePaymentsCybersecurity

    Portfolio: Welcome Software, Ecast

    Contact details available

  • Leigh Randall

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedConsumer Goods

    Portfolio: Codagenix

    Contact details available